Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2013
TITLE AUTHOR(S): M.Klopper, R.M.Warren, C.Hayes, N.C.G.Van Pittius, E.M.Streicher, B.Muller, F.A.Sirgel, M.Chabula-Nxiweni, E.Hoosain, G.Coetzee, P.D.Van Helden, T.C.Victor, A.P.Trollip
KEYWORDS: INFECTIOUS DISEASES, TREATMENT CENTRES, TUBERCULOSIS
DEPARTMENT: Public Health, Societies and Belonging (HSC)
Print: HSRC Library: shelf number 7676
HANDLE: 20.500.11910/3014
URI: http://hdl.handle.net/20.500.11910/3014
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.
Abstract
Factors driving the increase in drug-resistant tuberculosis (TB) in the Eastern Cape Province, South Africa, are not understood. A convenience sample of 309 drug-susceptible and 342 multidrug-resistant (MDR) TB isolates, collected July 2008-July 2009, were characterized by spoligotyping, DNA fingerprinting, insertion site mapping, and targeted DNA sequencing. Analysis of molecular-based data showed diverse genetic backgrounds among drug-sensitive and MDR TB sensu stricto isolates in contrast to restricted genetic backgrounds among pre-extensively drug-resistant (pre-XDR) TB and XDR TB isolates. Second-line drug resistance was significantly associated with the atypical Beijing genotype. DNA fingerprinting and sequencing demonstrated that the pre-XDR and XDR atypical Beijing isolates evolved from a common progenitor; 85% and 92%, respectively, were clustered, indicating transmission. Ninety-three percent of atypical XDR Beijing isolates had mutations that confer resistance to 10 anti-TB drugs, and some isolates also were resistant to para-aminosalicylic acid. These findings suggest the emergence of totally drug-resistant TB.-
Related Research Outputs:
- Bayesian approach in estimating risk determinants of infectious diseases
- Pyridoxal-5-phosphate plasma concentrations in children receiving tuberculosis chemotherapy including isoniazid
- Factors associated with tuberculosis reinfection and treatment failure in Taung sub-district, South Africa
- TB and HIV/TB co-infection: adherence to drug treatment in three selected provinces in South Africa
- Drug-resistant TB treatment: concerns over absconding patients
- Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa
- Ward councillors' and clinic committee members' views on the utility of maps for TB treatment adherence
- Urinary lipids as biomarkers during tuberculosis treatment
- Tuberculosis non-communicable disease comorbidity and multimorbidity in public primary care patients in South Africa
- Task oriented nursing in a tuberculosis control programme in South Africa: where does it come from and what keeps it going?
- Treatment centres of SA
- Monitoring alcohol and drug abuse trends in South Africa. Proceedings of South African Community Epidiology Network on Drug Use (SACENDU) report back meetings, March/April 2002; July-December 2001: Phase 11
- Monitoring alcohol and drug abuse trends in South Africa. Proceedings of SACENDU report back meetings October 2004: January - June 2004: Phase 16
- Perceptions of tuberculosis: attributions of cause, suggested means of risk reduction, and preferred treatment in the Limpopo province, South Africa
- Pathogen genomics and infectious diseases in Africa
- HIV/AIDS, tuberculosis and parasites
- Delivery of the directly observed therapy (DOT) for tuberculosis patients in the Limpopo province, South Africa: a qualitative study
- HIV/AIDS/STI/TB knowledge, beliefs and practices of traditional healers in KwaZulu-Natal, South Africa
- A controlled study of an HIV/AIDS/STI/TB intervention with traditional healers in KwaZulu-Natal, South Africa
- HIV/AIDS/STI/TB knowledge, attitudes and practices among lay health workers and nurses in KwaZulu-Natal, South Africa